Respiratory bacterial panel
ELITechGroup Molecular Diagnostics has recently launched a high-performance multiplex assay, the Respiratory Bacterial ELITe MGB Panel, for the diagnosis of bacterial respiratory infections, validated with ELITe InGenius, the company’s fully automated sample-to-result system.
Respiratory infections are common causes of morbidity and mortality worldwide. Regardless of the pathogen involved, similar symptoms can be observed making the diagnosis difficult to establish from only considering a symptom-based approach. Using a molecular diagnostic method is crucial to effectively determine the pathogens involved, prevent the misuse of antibiotics, and ensure an optimal patient management.
In combination with ELITe InGenius, the Respiratory Bacterial ELITEe MGB Panel is the first panel specifically designed to detect main relevant respiratory bacteria, CE-IVD validated with a sample-to-result system. Respiratory Bacterial ELITe MGB Panel detects and differentiates in one single reaction M. pneumoniae, C. pneumoniae, and L. pneumophila. The clinical study has demonstrated excellent performance: 100% diagnostic sensitivity and 100% diagnostic specificity were obtained with all targets.
The validation with ELITe InGenius offers many advantages to laboratories in comparison to other solutions available in the market: fully automated workflow from extraction to result interpretation, hand-on time reduced to a few minutes, and accurate results.
The CE-IVD ELITe InGenius respiratory menu will be further broadened in the coming months with a new Real-Time PCR assay for the detection of Mycobacterium tuberculosis and associated multidrug-resistant (rifampicin and isoniazid) forms.
